logo-loader
AIM:OBI OTC:OBIMF

Ondine Biomedical Inc

Receive alerts
Market:
AIM
Price
8.80 GBX
Day Change
1.73%
Market Cap:
£58.19 m
52 weeks high
15.50
52 weeks low
7.50

In brief

Ondine Biomedical Inc. is a Canadian life sciences company pioneering light-activated therapies designed to prevent and treat infections, including those caused by drug-resistant pathogens.

The company's patented photodisinfection platform technology targets harmful microbes without contributing to antimicrobial resistance, offering a powerful new approach to infection prevention.